Josephine Wu

Investment Committee member

Josephine has over 19 years of hedge fund, family office and global asset management experience including over 10 years of listed, pre-IPO and early stage Pan-Asia healthcare investment experience.

She has been CIO and portfolio manager with combined assets under management worth over US$5 billion.

She is the founder and CIO of Aionious Capital Limited, a dedicated healthcare investment company which invests and provides business development and commercialization strategies in the Pan-Asia region, specifically in China. She brings in an extensive network of experts in operation, clinical, market positioning and regulatory knowledge in the Pan-Asia healthcare landscape. Her investments in healthcare companies at different stages has led to a few successful commercialization launches of pharmaceutical products, regulatory approvals for decontamination solutions for hospitals and research centers, and the signing of strategic partnerships in commercialization transactions and IPOs.

Previously, she was Head of Asia Absolute return and alternative strategies at UBP; Managing Partner of Light & Salt Capital Management; Regional Portfolio Manager at Robeco HK Limited and Yu Ming Investments and General Partner at L-R Global Partners LP in New York.